121 related articles for article (PubMed ID: 15367651)
1. T-cell responses to the M3 immune evasion protein of murid gammaherpesvirus 68 are partially protective and induced with lytic antigen kinetics.
Obar JJ; Donovan DC; Crist SG; Silvia O; Stewart JP; Usherwood EJ
J Virol; 2004 Oct; 78(19):10829-32. PubMed ID: 15367651
[TBL] [Abstract][Full Text] [Related]
2. Latent antigen vaccination in a model gammaherpesvirus infection.
Usherwood EJ; Ward KA; Blackman MA; Stewart JP; Woodland DL
J Virol; 2001 Sep; 75(17):8283-8. PubMed ID: 11483773
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immunization with recombinant adenoviral vectors expressing murine gammaherpesvirus-68 genes M2 and M3 can reduce latent viral load.
Hoegh-Petersen M; Thomsen AR; Christensen JP; Holst PJ
Vaccine; 2009 Nov; 27(48):6723-30. PubMed ID: 19748577
[TBL] [Abstract][Full Text] [Related]
4. Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gammaherpesvirus 68 infection.
Freeman ML; Lanzer KG; Cookenham T; Peters B; Sidney J; Wu TT; Sun R; Woodland DL; Sette A; Blackman MA
J Virol; 2010 Mar; 84(6):2881-92. PubMed ID: 20053740
[TBL] [Abstract][Full Text] [Related]
5. Co-inoculation of DNA and protein vaccines induces antigen-specific T cell suppression.
Kang Y; Jin H; Zheng G; Du X; Xiao C; Zhang X; Geng S; Li X; Wang J; Chen A; Wang B
Biochem Biophys Res Commun; 2007 Feb; 353(4):1034-9. PubMed ID: 17204242
[TBL] [Abstract][Full Text] [Related]
6. ORF6 and ORF61 Expressing MVA Vaccines Impair Early but Not Late Latency in Murine Gammaherpesvirus MHV-68 Infection.
Samreen B; Tao S; Tischer K; Adler H; Drexler I
Front Immunol; 2019; 10():2984. PubMed ID: 31921215
[TBL] [Abstract][Full Text] [Related]
7. DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/c mice.
Barfoed AM; Rodriguez F; Therrien D; Borrego B; Sobrino F; Kamstrup S
Antiviral Res; 2006 Dec; 72(3):178-89. PubMed ID: 16890298
[TBL] [Abstract][Full Text] [Related]
8. Multiple epitopes in the murine cytomegalovirus early gene product M84 are efficiently presented in infected primary macrophages and contribute to strong CD8+-T-lymphocyte responses and protection following DNA immunization.
Ye M; Morello CS; Spector DH
J Virol; 2004 Oct; 78(20):11233-45. PubMed ID: 15452242
[TBL] [Abstract][Full Text] [Related]
9. Different functional capacities of latent and lytic antigen-specific CD8 T cells in murine gammaherpesvirus infection.
Obar JJ; Crist SG; Gondek DC; Usherwood EJ
J Immunol; 2004 Jan; 172(2):1213-9. PubMed ID: 14707099
[TBL] [Abstract][Full Text] [Related]
10. Plasmid DNA vaccines are effective in the absence of IFNgamma.
Hassett DE; Zhang J; Whitton JL
Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
[TBL] [Abstract][Full Text] [Related]
11. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
Gómez CE; Abaitua F; Rodríguez D; Esteban M
Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
[TBL] [Abstract][Full Text] [Related]
12. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
13. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
[TBL] [Abstract][Full Text] [Related]
14. Sortase-mediated modification of αDEC205 affords optimization of antigen presentation and immunization against a set of viral epitopes.
Swee LK; Guimaraes CP; Sehrawat S; Spooner E; Barrasa MI; Ploegh HL
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1428-33. PubMed ID: 23297227
[TBL] [Abstract][Full Text] [Related]
15. The CD8 T-cell response against murine gammaherpesvirus 68 is directed toward a broad repertoire of epitopes from both early and late antigens.
Gredmark-Russ S; Cheung EJ; Isaacson MK; Ploegh HL; Grotenbreg GM
J Virol; 2008 Dec; 82(24):12205-12. PubMed ID: 18922872
[TBL] [Abstract][Full Text] [Related]
16. Nasal peptide vaccination elicits CD8 responses and reduces viral burden after challenge with virulent murine cytomegalovirus.
Gopal IN; Quinn A; Henry SC; Hamilton JD; Staats HF; Frothingham R
Microbiol Immunol; 2005; 49(2):113-9. PubMed ID: 15722596
[TBL] [Abstract][Full Text] [Related]
17. T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice.
Liu L; Usherwood EJ; Blackman MA; Woodland DL
J Virol; 1999 Dec; 73(12):9849-57. PubMed ID: 10559297
[TBL] [Abstract][Full Text] [Related]
18. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.
Radosevic K; Wieland CW; Rodriguez A; Weverling GJ; Mintardjo R; Gillissen G; Vogels R; Skeiky YA; Hone DM; Sadoff JC; van der Poll T; Havenga M; Goudsmit J
Infect Immun; 2007 Aug; 75(8):4105-15. PubMed ID: 17526747
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of CD8(+) T-cell memory following infection with recombinant sindbis and vaccinia viruses.
Villacres MC; Zuo J; Bergmann CC
Virology; 2000 Apr; 270(1):54-64. PubMed ID: 10772979
[TBL] [Abstract][Full Text] [Related]
20. Protective immunity elicited by vaccination with DNA encoding for a B cell and a T cell epitope of the A/PR/8/34 influenza virus.
Casares S; Brumeanu TD; Bot A; Bona CA
Viral Immunol; 1997; 10(3):129-36. PubMed ID: 9344335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
